null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Pharmacology and Aphasia

List Price: $62.99
SKU:
9780367738921
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Marcelo Berthier, Guadeloupe Davila
    Format:
    Paperback
    Pages:
    146
    Publisher:
    Taylor & Francis (December 18, 2020)
    Language:
    English
    ISBN-13:
    9780367738921
    Weight:
    9.625oz
    Dimensions:
    6.875" x 9.6875"
    File:
    TAYLORFRANCIS-TayFran_260718044233672-20260718.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $62.99
    As low as:
    $59.84
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Audience:
    College/higher education
    Country of Origin:
    United States
    Pub Discount:
    30
    Imprint:
    Routledge
    Case Pack:
    1
  • Overview

    This book provides clinicians and researchers with the current state-of-the-art on the pharmacological treatment of aphasia. The focus is on the role of different pharmacological agents to improve aphasia associated with stroke and to attenuate language dissolution in degenerative conditions like Alzheimer’s disease and primary progressive aphasia. This book is the first one that addresses these topics. Leaders in the field provide tutorial reviews on how focal brain injury and degeneration impact on the normal the activity of different neurotransmitter systems and how drugs combined or not with rehabilitation can improve language and communication deficits. This is nicely illustrated by studies on single cases and case series describing the beneficial effects of interventions combining drugs with evidence-based rehabilitation techniques. Throughout the volume, future directions to refine testing aimed to detect gains in language and non-language cognitive deficits promoted by drug treatment are highlighted. This book is essential reading for anyone interested in the rehabilitation of aphasia and related cognitive disorders.



    This book was originally published as a special issue of Aphasiology.